Amneal Pharmaceuticals Inc Class A (AMRX)
Short-Term Debt
$121.42M
Quarterly · Period ending: · USD
AMRX Short-Term Debt
Latest reported$121.42Mperiod ending
Latest reported$121.42Mperiod ending
AMRX Quarterly Short-Term Debt ($36.99M → $121.42M)
Quarterly short-term debt
High-resolution chart · PNG
AMRX short-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Short-Term Debt (USD) |
|---|---|
| 121,421,000 | |
| 21,485,000 | |
| 21,576,000 | |
| 21,471,000 | |
| 335,406,000 | |
| 337,544,000 | |
| 340,255,000 | |
| 381,021,000 | |
| 451,646,000 | |
| 228,665,000 | |
| 227,624,000 | |
| 122,512,000 | |
| 166,477,000 | |
| 145,262,000 | |
| 104,639,000 | |
| 106,572,000 | |
| 131,130,000 | |
| 46,349,000 | |
| 46,037,000 | |
| 45,449,000 | |
| 43,705,000 | |
| 42,357,000 | |
| 57,474,000 | |
| 46,198,000 | |
| 47,075,000 | |
| 346,945,000 | |
| 36,954,000 | |
| 38,288,000 | |
| 38,051,000 | |
| 37,852,000 | |
| 21,715,000 | |
| 199,820,000 | |
| 99,478,000 | |
| 0 | |
| 89,482,000 | |
| 64,562,000 | |
| 0 | |
| 36,985,000 |